Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATEGaspar, N. ; Marshall, L.V. ; Binner, D. ; Herold, R. ; Rousseau, R. ; Blanc, P. ; Capdeville, R. ; Carleer, J. ; Copland, C. ; Kerloeguen, Y. ; Norga, K. ; Pacaud, L. ; Sevaux, M.-A. ; Spadoni, C. ; Sterba, J. ; Ligas, F. ; Taube, T. ; Uttenreuther-Fischer, M. ; Chioato, S. ; O'Connell, M.A. ; Geoerger, B. ; Blay, J.-Y. ; Soria, J.C. ; Kaye, S. ; Wulff, B. ; Brugières, L. ; Vassal, G. ; Pearson, A.D.J.Annals of oncology, 2018-03, Vol.29 (3), p.766-771 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: A reality or a myth?Vozy, A. ; Berlanga Charriel, P. ; Geoerger, B. ; Massard, C. ; Gaspar, N.Annals of oncology, 2018-10, Vol.29, p.viii713-viii713 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approachTan, D.S.W. ; Lassen, U.N. ; Albert, C.M. ; Kummar, S. ; van Tilburg, C. ; Dubois, S.G. ; Geoerger, B. ; Mascarenhas, L. ; Federman, N. ; Basu-Mallick, A. ; Doz, F. ; Berlin, J.D. ; Oh, D.-Y. ; Bielack, S. ; McDermott, R. ; Cruickshank, S. ; Ku, N.C. ; Cox, M.C. ; Drilon, A. ; Hong, D.S.Annals of oncology, 2018-11, Vol.29, p.ix23-ix23 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approachLassen, U N ; Albert, C M ; Kummar, S ; van Tilburg, C M ; Dubois, S G ; Geoerger, B ; Mascarenhas, L ; Federman, N ; Schilder, R J ; Doz, F ; Berlin, J D ; Oh, D-Y ; Bielack, S S ; McDermott, R ; Tan, D S ; Cruickshank, S ; Ku, N C ; Cox, M C ; Drilon, A ; Hong, D SAnnals of oncology, 2018-10, Vol.29 Suppl 8, p.viii133 [Periódico revisado por pares]EnglandTexto completo disponível |
|
5 |
Material Type: Artigo
|
277 INVITED IGF1R Targeting in Non-sarcoma Pediatric MalignanciesGeoerger, BEuropean journal of cancer (1990), 2011, Vol.47, p.S64-S65 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSé programVassal, G ; Cozic, N ; Houot, R ; Brugières, L ; Aparicio, T ; Blay, J-Y ; Perol, M ; Brice, P ; Meriaux, E ; Geoerger, B ; El Bejjani, M R ; Moalla, S ; Bièche, I ; Lantuejoul, S ; Mahier Ait Oukhatar, C ; Hoog Labouret, N ; Moro-Sibilot, DAnnals of oncology, 2018-10, Vol.29 Suppl 8, p.viii142 [Periódico revisado por pares]EnglandTexto completo disponível |
|
7 |
Material Type: Artigo
|
Phase 1 study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK): Safety, pharmacokinetics and efficacy results from the fed populationFischer, M ; Wulff, B ; Baruchel, S ; Berlanga, P ; Trahair, T ; Mechinaud, F ; Schulte, J ; Modak, S ; Merks, J.H ; Zwaan, C.M ; Marshall, L.V ; Casanova, M ; Branle, F ; Malet, I ; Emeremni, A.C ; Geoerger, BEuropean journal of cancer (1990), 2016-12, Vol.69, p.S49-S50 [Periódico revisado por pares]Oxford: Elsevier Science LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
347 Efficacy of Dasatinib in Targeting Diffuse Intrinsic Pontine Glioma (DIPG) Specific Pathway Activation in VitroTruffaux, N ; Puget, S ; Vassal, G ; Geoerger, B ; Grill, JEuropean journal of cancer (1990), 2012-11, Vol.48, p.106-106 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trialsDoussau, A. ; Thiébaut, R. ; Geoerger, B. ; Schöffski, P. ; Floquet, A. ; Le Deley, M.C. ; Mathoulin-Pélissier, S. ; Rizzo, E. ; Fumoleau, P. ; Le Tourneau, C. ; Paoletti, X.Annals of oncology, 2015-02, Vol.26 (2), p.422-428 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenograftsGeoerger, B ; Grill, J ; Opolon, P ; Morizet, J ; Aubert, G ; Lecluse, Y ; van Beusechem, V W ; Gerritsen, W R ; Kirn, D H ; Vassal, GBritish journal of cancer, 2003-08, Vol.89 (3), p.577-584 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |